TextbookCardiologyComplete Heart Block

Complete Heart Block

Complete failure of conduction between atria and ventricles (third-degree AV block) with independent atrial and ventricular rhythms. Requires urgent pacing in most acquired cases.

Key Facts

Complete AV dissociation: P waves and QRS complexes are independent with no relationship between them Ventricular escape rate: junctional escape 40-60 bpm (narrow QRS) or ventricular escape 20-40 bpm (broad QRS) Common causes: degenerative conduction disease (most common in elderly), inferior/anterior MI, post-cardiac surgery, drugs Broad QRS escape rhythm carries higher risk of asystole and is more haemodynamically unstable Treatment: permanent pacemaker is definitive treatment for symptomatic or acquired complete heart block Atropine may be used acutely but is often ineffective in infra-nodal block; isoprenaline or temporary pacing preferred Congenital CHB: associated with maternal anti-Ro/La antibodies (neonatal lupus) and structural heart defects Post-inferior MI: may be transient; post-anterior MI indicates extensive septal necrosis with poor prognosis

Overview

Key Facts

Complete heart block (third-degree AV block) is characterised by complete absence of conduction between the atria and ventricles. The atria and ventricles beat independently, with the ventricles relying on an escape rhythm at a rate slower than the sinus rate.

Epidemiology

  • Incidence increases with age: rare in young adults, common in elderly
  • Leading indication for permanent pacemaker implantation worldwide
  • Congenital CHB: incidence ~1 in 15,000-20,000 live births
  • Accounts for ~5-10% of acute MI cases with conduction disturbance

Aetiology

Acquired (most common):

  • Degenerative: idiopathic fibrosis of the conduction system (Lenegre/Lev disease) — commonest cause in elderly
  • Ischaemic: inferior MI (usually transient, AV nodal), anterior MI (usually permanent, infra-nodal)
  • Drugs: beta-blockers, CCBs, digoxin toxicity, amiodarone
  • Post-surgical: aortic valve replacement, TAVI, septal myectomy
  • Inflammatory: myocarditis, endocarditis, rheumatic fever, Lyme disease
  • Infiltrative: sarcoidosis, amyloidosis, haemochromatosis
  • Autoimmune: SLE (anti-Ro antibodies)

Congenital:

  • Maternal anti-Ro (SS-A) and anti-La (SS-B) antibodies (neonatal lupus)
  • Structural congenital heart disease (corrected TGA, AV canal defects)

Pathophysiology

  • Complete interruption of electrical conduction between atria and ventricles
  • Atrial rhythm driven by SA node; ventricular rhythm driven by escape pacemaker
  • Junctional escape (narrow QRS, 40-60 bpm): block at AV node, more reliable
  • Ventricular escape (broad QRS, 20-40 bpm): block below His bundle, unreliable and prone to asystole
  • Cardiac output reduced due to loss of AV synchrony and slow ventricular rate

Clinical Presentation

Typical Presentation

  • Symptomatic bradycardia: dizziness, presyncope, syncope (Stokes-Adams attacks)
  • Fatigue, exercise intolerance, dyspnoea
  • Heart failure symptoms if prolonged

Examination Findings

  • Slow regular pulse (escape rate)
  • Variable intensity of S1 (due to changing PR relationship)
  • Cannon 'a' waves in JVP (atria contracting against closed tricuspid valve)
  • Wide pulse pressure

Red Flags

  • Syncope or Stokes-Adams attacks
  • Haemodynamic instability: hypotension, shock
  • Broad QRS escape rhythm (unreliable, risk of asystole)
  • New complete heart block in anterior MI
  • Heart failure or pulmonary oedema
  • Associated with VT/VF (long QT from slow rate may trigger TdP)

Differential Diagnosis

DiagnosisKey FeaturesInvestigation
High-grade second degree blockSome P waves conducted, not allECG
Sinus bradycardiaRegular slow rate, normal PR, normal AV conductionECG
Junctional rhythmNo preceding P waves, narrow QRS, rate 40-60 bpmECG
HyperkalaemiaBroad QRS, peaked T waves, sine wave patternU&Es
HypothyroidismBradycardia, fatigue, cold intoleranceTFTs
Beta-blocker/CCB overdoseDrug history, bradycardia, hypotensionDrug history, levels

Diagnosis / Investigation

Bedside

  • 12-lead ECG: AV dissociation, escape rhythm rate and QRS width
  • Continuous cardiac monitoring: essential — risk of asystole
  • Observations: HR, BP, SpO₂

Bloods

  • U&Es: potassium, magnesium, calcium
  • Troponin: if MI suspected
  • Digoxin level: if applicable
  • TFTs: hypothyroidism
  • FBC, CRP: if inflammatory cause suspected
  • Lyme serology: if epidemiological risk
  • Anti-Ro/La antibodies: if congenital or young patient with SLE features

Imaging

  • Echocardiography: structural heart disease, LV function, valve disease
  • Cardiac MRI: sarcoidosis, myocarditis
  • Chest X-ray: cardiac size, pulmonary oedema

Special Tests

  • Electrophysiology study: rarely needed for complete heart block (diagnosis usually clinical)
  • Genetic testing: in congenital cases if familial

Management

Non-pharmacological

  • Admit to monitored bed (CCU/HDU)
  • External transcutaneous pacing pads applied as standby
  • Lie patient flat if hypotensive

Pharmacological

Acute management (per Resuscitation Council UK bradycardia algorithm):

  • Atropine 500 mcg IV (repeat up to 3mg): may be effective for nodal block, often ineffective for infra-nodal
  • Isoprenaline infusion 1-10 mcg/min: increases ventricular rate; bridging to pacing
  • Adrenaline infusion 2-10 mcg/min: if isoprenaline unavailable
  • Treat reversible causes: correct electrolytes, stop culprit drugs, treat MI

Surgical/Interventional

  • Temporary transvenous pacing: urgently if haemodynamically compromised or broad QRS escape
  • Transcutaneous pacing: bridge to transvenous pacing in emergency
  • Permanent pacemaker implantation: definitive treatment for acquired symptomatic CHB
    • Dual-chamber pacemaker (DDD) is standard
    • Rate-responsive pacing for chronotropic incompetence
    • NICE recommends within 24-48 hours if no reversible cause
  • Congenital CHB: pacemaker if symptomatic, resting HR <50 bpm, broad QRS escape, or associated structural defect

Referral Criteria

  • All acquired complete heart block: urgent cardiology referral
  • Temporary pacing as bridge to permanent pacemaker
  • Post-MI CHB: assess need for permanent pacing before discharge

Prognosis

  • Without pacing: significant mortality, especially with broad QRS escape (risk of asystole)
  • With permanent pacemaker: near-normal life expectancy
  • Post-inferior MI CHB: often transient (resolves in ~70% within 7 days), rarely needs permanent pacing
  • Post-anterior MI CHB: poor prognosis (extensive infarction), even with pacing; mortality ~60-80%
  • Congenital CHB with narrow QRS and no structural defect: generally favourable with monitoring; pacing if symptomatic
  • Pacemaker complications: infection (~1-2%), lead displacement (~2-3%), generator replacement every 7-15 years

Other Relevant Information

Resuscitation Council UK Bradycardia Algorithm Summary

StepAction
1Assess ABCDE, IV access, monitoring, 12-lead ECG
2Identify adverse features: shock, syncope, heart failure, myocardial ischaemia
3If adverse features: atropine 500mcg IV
4If no response: consider temporary pacing, isoprenaline, or adrenaline
5Seek expert help for definitive management

Escape Rhythm Characteristics

Level of BlockQRS WidthEscape RateReliability
AV nodalNarrow40-60 bpmMore reliable
His bundleNarrow or wide30-50 bpmIntermediate
Below HisWide20-40 bpmUnreliable, asystole risk